Search Results 941-950 of 21351 for anti-TNF drugs

  1. Molnupiravir (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Lagevrio. Descriptions. Molnupiravir is used to treat mild ...

  2. Epoprostenol (Intravenous Route) Description and Brand Names - Mayo Clinic

    Epoprostenol belongs to a group of agents called prostaglandins. Prostaglandins occur naturally in the body and are involved in many biological functions.

  3. Triamcinolone (Nasal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Norgestrel, Ethinyl Estradiol, And Ferrous Fumarate (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Methylphenidate (Oral Route) Description and Brand Names - Mayo Clinic

    Methylphenidate is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central nervous system (CNS) ...

  6. Phenylephrine (Ophthalmic Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  7. Sulfamethoxazole And Trimethoprim (Oral Route) Proper Use - Mayo Clinic

    For treatment of Pneumocystis jiroveci pneumonia or Pneumocystis carinii pneumonia (PCP):. Adults and children 2 months of age and older—Dose is based on body ...

  8. Nortriptyline (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... [TNFα] antagonists, ustekinumab, vedolizumab) and ... Adalimumab 40 mg qwk > 7.5mg/ml Certolizumab 400 mg ...

  10. Rituximab Vasculitis Maintenance Study - Mayo Clinic

    Rituximab is now established as an effective drug for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis following major European and US trials reported in ...